Ultra-Low-Temperature Freezers for COVID-19 Vaccines
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines.
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines. Designed with enhanced robustness, efficiency, and ergonomics, the freezers come equipped with vacuum panels for high levels of insulation to uphold a temperature of -80 ºC with ambient temperatures up to +28 ºC. Instead of using polyurethane foam like many standard freezers, Boreas feature a thinner inner insulation for an enlarged storage capacity of up to 30%. Additionally, the freezers use high purity natural refrigerant CFC free gases that contribute to environment preservation.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
